Swiss Re AG (SREN.SW) Q1 2026 Earnings Call Transcript
Bullish Insurance - Reinsurance 50.93B Switzerland
Next Earnings
2026-05-07
There is no Profile data available for SR9.SG.
Swiss Re posted a record 2025 net income, reinforced resilience with higher loss reserves, and announced substantial capital returns including an extraordinary USD 1 billion buyback alongside a raised dividend.
⭐ Key Highlights
Record group net income
Swiss Re delivered a record group net income of USD 4.8 billion in 2025, beating the target of over USD 4.4 billion, with ROE at 20%.
Balance-sheet resilience and reserves
The group strengthened resilience by increasing initial loss assumptions, adding to reserves in P&C Re and Life & Health Re, and tightening exposure via an ongoing review process.
Cost reduction and efficiency
Achieved more than USD 100 million in cost savings in 2025, on track to reach a USD 300 million run-rate cost reduction by 2027.
Renewals and market conditions
January 2026 renewals were in line with expectations, with remaining favorable pricing/structural adjustments, while nat cat exposure modestly increased due to lower external retro.
Capital deployment and shareholder return
Announced USD 1 billion extraordinary buyback in addition to the dividend and a USD 500 million sustainable buyback, supported by a strong SST ratio of 250% and USD 4.7 billion SST capital generation in 2025.
✔Positive Signals
- Record group net income of USD 4.8 billion in 2025 and ROE of 20%
- Renewals for January 2026 broadly in line with expectations with disciplined underwriting
- Cost savings of >USD 100 million in 2025, on track for USD 300 million by 2027
- Dividend increase to USD 8 per share and USD 1 billion extraordinary buyback
- Strong SST capital generation and a robust SST ratio of 250%
✖Negative Signals
- Prudent increase in loss assumptions (4.6% overall) and higher reserves impacting short-term P&L
- Life & Health Re portfolio reviews reduced 2025 revenues in some segments and volatility in CSM balance
- New business CSM impact uncertain with guidance implying stabilization rather than growth
- Increased net nat cat exposure due to reduced retro, potential for higher volatility in renewals
- Top-line volatility and earnings variability in 2025, with execution-dependent guidance for 2026
📊Financial Results
- Insurance service results: P&C Re USD 3.6 billion (2025) vs prior year; Corporate Solutions USD 1.2 billion; Life & Health Re USD 1.2 billion
- Revenues: Group insurance revenue USD 43.1 billion (2025) versus USD 45.6 billion prior year
- Investments: ROI 4.0% with recurring investment income of USD 4.0 billion; Definity sale and targeted fixed income losses noted
- Capital: USD 8 per share dividend proposed; USD 1 billion extraordinary buyback; USD 500 million sustainable buyback; SST ratio 250%
🔮Future Guidance
- 2026 group net income target of USD 4.5 billion
- Ongoing cost reduction trajectory: USD 300 million run-rate operating-cost reduction by 2027
- Dividend target growth of at least 7% per year 2025-2027, with ongoing buyback policy including potential extraordinary actions if capital allows
💡Interesting Insights
- Strategic shift to in-house retention of nat cat capacity and reduced retro, signaling a deliberate balance between resilience and market dynamics
Detailed Analysis
AI-generated summary of Swiss Re AG earnings call transcript.
In 2025 Swiss Re achieved a record group net income of USD 4.8 billion and an ROE of 20%, driven by disciplined underwriting, robust recurring investment income, and lower large-loss burden outside Q1. The company strengthened resilience through the Life & Health Re portfolio review, higher initial loss assumptions, and additional reserves in P&C Re, while pursuing cost reductions of over USD 100 million and targeting USD 300 million in annual run-rate cost savings by 2027. P&C Re delivered an excellent combined ratio of 79.4% and Corporate Solutions 86.5% (80% like-for-like), reflecting a high-quality portfolio and favorable experience. The renewals for January 2026 were in line with expectations, with a subsidy-like shift in pricing and increased nat cat exposure due to reduced external retro. Life & Health Re remained a stable earnings pillar, delivering USD 1.3 billion net income for 2025 and guiding toward USD 1.7 billion for 2026. The group confirmed 2026 guidance of USD 4.5 billion in net income, announced a USD 8 per share dividend hike, and disclosed a USD 1 billion extraordinary buyback plus a USD 500 million sustainable buyback, underpinned by a strong SST ratio and capital generation of USD 4.7 billion in 2025.
Get Real-Time Earnings Call Alerts for Swiss Re AG
Create a free MarketAlerts account to add SREN.SW to your watchlist and receive instant AI-powered alerts when new earnings call transcripts, insider trades, and technical signals are detected.
Other MarketAlerts Features
